PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.4851
+0.0171 (3.65%)
At close: Aug 29, 2025, 4:00 PM
0.4950
+0.0099 (2.04%)
After-hours: Aug 29, 2025, 7:42 PM EDT
PAVmed Market Cap
PAVmed has a market cap or net worth of $8.39 million as of August 29, 2025. Its market cap has increased by 11.86% in one year.
Market Cap
8.39M
Enterprise Value
13.32M
1-Year Change
11.86%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $8.39M, a decrease of -95.15%. That is a compound annual growth rate of -28.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 10.60M | 53.62% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
| Jul 28, 2016 | 173.00M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 656.38B |
| Johnson & Johnson | 426.08B |
| AbbVie | 371.03B |
| UnitedHealth Group | 277.22B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 230.44B |